Updated:
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001556263, and its reported...
Overview
Syros Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001556263, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-27, it reported annual revenue of USD 9,936,000; net income of USD -164,574,000; total assets of USD 168,174,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Syros Pharmaceuticals, Inc.
- Former names in filing history
- LS22, Inc. (2012-08-22 to 2012-08-22)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Cambridge, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001556263
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2023USD | $9.9M | -$164.6M | $168.2M | $139.5M | -$109.7M | |
| FY2022USD | $14.9M | -$94.7M | $244.5M | $167.5M | -$123.1M | |
| FY2021USD | $23.5M | -$86.6M | $182.9M | $92.3M | -$99.5M | |
| FY2020USD | $15.1M | -$84.0M | $213.3M | $174.0M | -$57.4M |
FY2021. Net income: shown as originally filed; later filings report different values for the same periods.
FY2020. Net income: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Syros Pharmaceuticals, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.